Latest California Healthline Stories
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Abortion-Rights Supporters Fear Loss Of Access If Adventist Saves Hospital
As community hospitals struggle, they often turn to large religious-based hospital groups to bail them out. But that can limit the types of services they offer, especially reproductive health treatment such as abortion.
Must-Reads Of The Week From Brianna Labuskes
Happy Friday! In news that is technically really good and exciting but is also kind of icky: yarn made from human skin could eventually be used to stitch up surgical wounds as a way to cut down on detrimental reactions from patients. As CNN reports, “The researchers say their ‘human textile,’ which they developed from […]
Women Shouldn’t Get A Bill For An IUD … But Sometimes They Do
The Affordable Care Act requires that insurers cover birth control with no out-of-pocket costs, but the enforcement mechanism is weak and a pending court case could add further complications.
Patients Caught In Crossfire Between Giant Hospital Chain, Large Insurer
Insurance giant Cigna and San Francisco-based Dignity Health have failed to ink a 2020 contract, leaving nearly 17,000 patients in California and Nevada scrambling to find new health care providers. Meanwhile, Dignity faces financial and legal challenges while it strives to implement its merger with Catholic Health Initiatives, which created one of the nation’s largest Catholic hospital systems.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Conceived Through ‘Fertility Fraud,’ She Now Needs Fertility Treatment
Years ago, doctors sometimes lied about whose sperm they used for artificial inseminations. Could it happen now? Some argue regulation is weak in the multibillion-dollar fertility treatment industry.
Call For FDA To Withdraw Preterm Birth Drug Divides Doctors and Insurers
A study ordered by the Food and Drug Administration failed to prove that Makena, the only drug approved to prevent premature birth, is effective. While a panel of experts has recommended withdrawing the drug’s approval, many doctors are wary.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
With Fate Of Roe V. Wade Unsure, Abortion Fight Shifts To New Territory
The Supreme Court in March will hear a Louisiana case that tests whether the new five-member conservative majority is willing to overturn the 1973 decision that made abortion legal nationwide. Even if the court does not go that far, it could hasten the procedure’s demise by saying abortion providers cannot sue on behalf of their patients.